Perspectum Diagnostics

Medical technology
Perspectum Diagnostics has developed Medical Imaging technologies to diagnose and measure the treatments of liver disease using Magnetic Resonance.

Addressing the challenge
Perspectum Diagnostics initially sought help with funding to assist the adoption of its product LiverMultiScan in the UK, US and across Europe. In addition, it was recognised that business support was needed to help the company expand and cope with growth.

Writing grant applications for Horizon 2020 funding.
Oxford Innovation assisted in writing grant applications for Horizon 2020 funding. Perspectum Diagnostics was successful in winning €3.4million of funding through the SME Instrument to help with the EU adoption of the LiverMultiScan.
In addition, Perspectum Diganostics was awarded a further €1.1million of Eurostars funding to develop R&D centralised analysis and diagnostics for complex paediatric liver disease in collaboration with a Polish software company.

The University of Oxford spin-out has more than tripled its headcount in addition to opening two US offices in the last two years due to the success of the LiverMultiScan.

Quote Icon

“Thanks to Oxford Innovation & EEN support, and their market knowledge covering Central and Eastern Europe, we were able to create winning applications under both of the SME Instrument phases and also Eurostars.

 – Rajarshi Banerjee, CEO & Founder”.


Tap into our insights

Oxford Innovation Advice offers Insights into SME needs and policy effectiveness for policy makers, funders and business support commissioners. It draws on our 30 years’ experience of delivering positive economic growth by enabling scale-ups to achieve their full potential. Each edition concludes with an ‘Implications for funders and Policy makers’ section.

Oxford Innovation Logo

Covid-19 Statement

Update – Wednesday 15th December 2021

Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.